Cargando…

Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan

BACKGROUND: Chemotherapy-induced acute exacerbation (AEx) of idiopathic interstitial pneumonias (IIPs) seriously compromises the success of treatment of Japanese lung cancer patients. Here, we conducted a nationwide surveillance to clarify the risk of AEx and compare it with the survival benefit of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minegishi, Yuji, Gemma, Akihiko, Homma, Sakae, Kishi, Kazuma, Azuma, Arata, Ogura, Takashi, Hamada, Naoki, Taniguchi, Hiroyuki, Hattori, Noboru, Nishioka, Yasuhiko, Tanizawa, Kiminobu, Johkoh, Takeshi, Yokoyama, Takuma, Mori, Kazutaka, Taguchi, Yoshio, Ebina, Masahito, Inase, Naohiko, Hagiwara, Koichi, Ohnishi, Hiroshi, Mukae, Hiroshi, Inoue, Yoshikazu, Kuwano, Kazuyoshi, Chiba, Hirofumi, Ohta, Ken, Tanino, Yoshinori, Sakai, Fumikazu, Sugiyama, Yukihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248335/ https://www.ncbi.nlm.nih.gov/pubmed/32494570 http://dx.doi.org/10.1183/23120541.00184-2019

Ejemplares similares

Design of phase 2 study of TAS-115, a novel oral multi-kinase inhibitor, in patients with idiopathic pulmonary fibrosis
por: Nishioka, Yasuhiko, et al.
Publicado: (2021)

Primary ciliary dyskinesia caused by a large homozygous deletion including exons 1–4 of DRC1 in Japanese patients with recurrent sinopulmonary infection
por: Keicho, Naoto, et al.
Publicado: (2019)

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial
por: Taniguchi, Hiroyuki, et al.
Publicado: (2011)

Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
por: Kondoh, Yasuhiro, et al.
Publicado: (2020)

Rare case of pulmonary sarcoidosis with cystic bronchiectasis
por: Sugino, Keishi, et al.
Publicado: (2020)

Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
por: Ogura, Takashi, et al.
Publicado: (2023)

Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan
por: Hattori, Takeshi, et al.
Publicado: (2018)

Reply to Kobayashi et al.: Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kondoh, Yasuhiro, et al.
Publicado: (2020)

Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan
por: Ikeda, Kimiyuki, et al.
Publicado: (2020)

Elective lung resection after treatment for COVID-19 pneumonia
por: Sakai, Takashi, et al.
Publicado: (2021)

Infected lung bulla caused by Neisseria elongata: A case report
por: Moriya, Tetsuji, et al.
Publicado: (2022)

Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non-small-cell lung cancer
por: Gemma, Akihiko, et al.
Publicado: (2014)

Impact of accurate diagnosis of interstitial lung diseases on postoperative outcomes in lung cancer
por: Azuma, Yoko, et al.
Publicado: (2022)

Exophiala dermatitidis pneumonia with bronchiectasis required prolonged voriconazole treatment
por: Sekiguchi, Ryo, et al.
Publicado: (2021)

Upregulation of long non‑coding RNA LINC00460 in EGFR‑mutant lung cancer indicates a poor prognosis in patients treated with osimertinib
por: Nakano, Yuta, et al.
Publicado: (2023)

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
por: Hisanaga, Kaori, et al.
Publicado: (2021)

Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer
por: Ono, Hiroshi, et al.
Publicado: (2014)

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment
por: Azuma, Arata, et al.
Publicado: (2011)

Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
por: Sugino, Keishi, et al.
Publicado: (2021)

Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy
por: Kataoka, Kensuke, et al.
Publicado: (2023)

Clinical importance of long non-coding RNA LINC00460 expression in EGFR-mutant lung adenocarcinoma
por: Nakano, Yuta, et al.
Publicado: (2019)

Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease
por: Isshiki, Takuma, et al.
Publicado: (2022)

Efficacy of three sputum specimens for the diagnosis of Mycobacterium avium complex pulmonary disease
por: Urabe, Naohisa, et al.
Publicado: (2023)

Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis
por: Inomata, Minoru, et al.
Publicado: (2015)

Nationwide retrospective observational study of idiopathic dendriform pulmonary ossification: clinical features with a progressive phenotype
por: Nishioka, Yasuhiko, et al.
Publicado: (2022)

Immunohistochemical Detection of Propionibacterium acnes in Granulomas for Differentiating Sarcoidosis from Other Granulomatous Diseases Utilizing an Automated System with a Commercially Available PAB Antibody
por: Isshiki, Takuma, et al.
Publicado: (2021)

Clinical Course and Changes in High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without Honeycombing
por: Yamauchi, Hiroyoshi, et al.
Publicado: (2016)

Variation in information needs of patients with interstitial lung disease and their family caregivers according to long-term oxygen therapy: a descriptive study
por: Sato, Ryuhei, et al.
Publicado: (2023)

Association of rs3750920 polymorphism in TOLLIP with clinical characteristics of fibrosing interstitial lung diseases in Japanese
por: Isshiki, Takuma, et al.
Publicado: (2021)

Determinants of Six-Minute Walk Distance in Idiopathic Pulmonary Fibrosis and Idiopathic Pleuroparenchymal Fibroelastosis
por: Sato, Naofumi, et al.
Publicado: (2022)

Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma
por: Mishima, Yuka, et al.
Publicado: (2018)

A patient with sudden hearing loss induced by propylthiouracil
por: Tanabe, Katsuya, et al.
Publicado: (2021)

Clinical features of the 2009 swine-origin influenza A (H1N1) outbreak in Japan
por: Takayama, Koji, et al.
Publicado: (2010)

Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
por: Sugino, Keishi, et al.
Publicado: (2021)

Benefits of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Drug Treatment
por: Iwanami, Yuji, et al.
Publicado: (2022)

Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
por: Sugiura, Makiko, et al.
Publicado: (2015)

Cost of shifting from healthcare to long-term care in later life across major diseases: analysis of end-of-life care during the last 24 months of life
por: Terada, Tomoko, et al.
Publicado: (2018)

Impact of chronic co-infection in pulmonary Mycobacterium avium complex disease after treatment initiation
por: Urabe, Naohisa, et al.
Publicado: (2022)

Computed Tomography Images of Fibrotic Pulmonary Sarcoidosis Leading to Chronic Respiratory Failure
por: Sawahata, Michiru, et al.
Publicado: (2020)

Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion
por: Fujisawa, Tomoyuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4eulg1dgnrfsav10i3fp9hthpo